Vortioxetine (vor-tye-OX-e-teen trade name Brintellix previously known as Lu AA21004) is an atypical antidepressant made by Lundbeck and Takeda. On September 30 2013 it was approved by the U.S. FDA for the treatment of major depressive disorder (MDD) in adults.
This page contains content from the copyrighted Wikipedia article "Vortioxetine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
